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Aortic valve is less severely affected in paradoxical low gradient than
in high gradient severe aortic stenosis
Jamila Boulif, Bernhard Gerber, Siham Lazam, Christophe De Meester,
Agnès Pasquet, David Vancraeynest, Jean-Louis Vanoverschelde
Université Catholique de Louvain, Institut de Recherche Expérimentale et
Clinique, Bruxelles, Belgique
Background: Paradoxical low gradient (PLG) severe aortic stenosis (SAS)
is a recently described subset of SAS, which is a matter of intense debate.
Some authors indeed consider this new entity as a more advanced form of
SAS, whereas others believe the opposite. To get further insight into the
pathophysiology of PLG SAS, we compared the weight of the valves
explanted at the time of surgery (AVR) and the degree of valve calcification
among consecutive patients with PLG SAS and high-gradient (HG) SAS.
Methods: We prospectively recruited 38 consecutive patients (20 men;
mean age: 73 yrs) with isolated non-rheumatic SAS (indexed aortic valve area
(AVAi) < 0.6 cm²/m²). Prior to AVR, patients underwent multidetecor cardiac
CT to measure the aortic valve Agatston calcium score. After AVR, the aortic
leaflets were weight on a high precision scale and were subsequently placed
into the CT scanner to measure the valve calcium score ex-vivo.
Results: PLG and HG SAS had similar baseline characteristics with the
exception of AVAi which was higher (0.44±0.06 vs 0.36±0.10 cm²/m²,
p=0.008) and MG which was lower (32±7 vs 55±12 mmHg, p<0.001) in PLG
than in HG SAS. Analysis of valve specimens demonstrated a high degree of
covariance between ex-vivo and in-vivo Agatston scores (r²=0.78) as well as
between valve weight and both ex-vivo (r²>0.90) and in-vivo (r²=0.71)
Agatston scores. Interestingly, valves explanted from patients with PLG SAS
were lighter (1.58±0.65 vs 2.65±1,24g, p=0.001) and showed lower ex-vivo
Agatston scores (363±282 vs 1211±840, p<0.001) than HG SAS valves. These
differences remained significant after adjustment for gender (p=0.011 for
valves weight and p=0.002 for ex-vivo Agatston score).
Conclusion: The valves weight and degree of valve calcification reported
in our study indicate that PLG SAS valves are less severely affected than HG
SAS valves. These data thus reinforce the hypothesis that PLG SAS is a lesser
advanced form of aortic stenosis than HG SAS.
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Outcomes of patients undergoing femoral covered stent graft during
percutaneous transcatheter aortic valve implantation
Guillaume Cellier, Christophe Tron, Eric Durand, Matthieu Godin,
Safwane El Hatimi, Guillaume Viart, Najime Bouhzam, Hélène Eltchani-
noff
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Although vascular complications are frequent after percutaneous transcatheter
aortic valve implantation (TAVI), they can be managed percutaneously most of
the time by implanting a covered stent graft in the femoral artery.
Aims: To evaluate the characteristics of patients who required femoral
stent implantation after TAVI and to determine the long-term impact of stent
placement in the femoral position.
Methods: Between January 2011 and December 2013, 320 patients under-
went transfemoral TAVI in our center using the Edwards Sapien XT valve.
After gaining vascular access, a pre-closure technique was performed with a
10-F ProStar XL closure device followed by16 to 20-F sheath insertion for 23,
26 or 29mm valve implantation. After valve implantation and sheath removal,
access site was closed with the ProStar device. An ilio-femoral angiography
was performed via the contralateral femoral artery to assess final result and a
self-expandable covered stent graft was placed at the level of vessel injury in
case of persistent bleeding despite prolonged manual compression or balloon
occlusion. Follow-up was performed by phone call and duplex ultrasono-
graphy of the access site.
Results: 29 (9%) patients required emergency femoral covered stent graft
implantation. Patients characteristics were comparable to those of patients
who did not require stent implantation except for previous anticoagulant
therapy which was significantly associated with stent implantation (44.8 % vs
27.1 %, p = 0.045). Despite stent implantation, 2 patients underwent surgery
for persistent bleeding. Stent implantation did not affect survival (p=0.456).
At a median follow-up of 23 months, only 1 patient complained of groin dis-
comfort impacting his daily life. Neither stent fracture nor occlusion was
noted by ultrasonography.
Conclusion: Vascular complications after TAVI can be safely treated per-
cutaneously by femoral covered stent graft with minimal long-term functional
impairment and no impact on survival.
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Systolic volume index by Doppler echocardiography is a useful mar-
ker for stratification and prognostic evaluation in Algerian patients
with severe aortic stenosis and preserved ejection fraction
Hocine Foudad, Ilyas Bouaguel, Aziz Trichine, Rachid Merghit
Hôpital Militaire, Cardiologie, Constantine, Algérie
Introduction and Objectives: The prognosis of patients with severe aortic
stenosis, low aortic gradient and preserved ejection fraction is controversial.
Our study analyzed the prognosis of these patients and its relation to pressure
gradient and aortic valve flow.
Methods: We performed a retrospective cohort study of 268 consecutive
patients with severe aortic stenosis and preserved ejection fraction, divided
into 4 groups, based on the presence of a systolic volume index greater or
lower than 35mL/m2 and the presence of a mean aortic gradient greater or
lower than 40 mmHg. Group I: normal flow, high gradient (n=126, 47%);
group II: normal flow, low gradient (n=72, 27%); group III: low flow, high
gradient (n=40, 15%), and group IV: low flow, low gradient (n=30, 12%). The
primary endpoint was overall mortality.
Results: Independent risk factors for mortality were age (hazard
ratio=1.06; 95% confidence interval, 1.01-1.08) and atrial fibrillation (hazard
ratio=2.19; 95% confidence interval, 1.24-3.94). Surgical treatment was asso-
ciated with longer survival in all groups (hazard ratio=0.27; 95% confidence
interval: 0.13-0.49). Mortality was higher in patients with low flow than in
those with with normal flow (27.8% vs 13.9%; P=.004). The most favorable
mean prognosis was found in group II (hazard ratio=0.4; 95% confidence
interval, 0.2-0.9).
Conclusions: Patients with severe aortic stenosis, normal ejection fraction
and low aortic flow have a worse prognosis. Analysis of aortic flow by Dop-
pler echocardiography is useful in risk stratification and therapeutic decision-
making in patients with aortic stenosis.
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Left bundle branch block after transcatheter aortic valve implanta-
tion: incidence, predictive factors and outcome
Audrey Lefoulon, Laurence Jesel, Halim Marzak, Nathan Messas, Michel
Chauvin, Olivier Morel, Patrick Ohlmann
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Purpose: Conduction disorders are frequent after transcatheter aortic valve
implantation (TAVI). The aim of the study was to assess the incidence, the
clinical impact and the predictive factors of new-onset left bundle branch
block (LBBB) after TAVI.
Methods: Between 2010 and 2014, 198 consecutive patients underwent
TAVI in our center and 156 were prospectively followed during 1 year (62
CoreValve (CV), 94 Edwards Sapiens valve (ES)). 42 patients were excluded
because of a pre-existing PM before TAVI, death or surgery after TAVI.
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Results: After 156 TAVI, 40 patients (26%) required pacemaker implanta-
tion. CV patients were more frequently implanted than ES (35% vs 19%;
p=0.03). Out of 116 non-implanted patients, 53 (46%) patients presented with
LBBB which persisted in 35 (30%) patients. QRS width increased +27ms in
post-procedure, +21ms at hospital discharge, +15ms at 1 month, +11ms at
1 year in the whole cohort. There was no clinical nor echocardiographic dif-
ference between the LBBB group and no-LBBB group. Ischemic neurological
complication were more frequent during hospitalization in the LBBB group
(8.6% vs 3.7%; p=0.007). 
On multivariate analysis, a pre-existing incomplete LBBB (OR 4.15; IC
1.31-13.11; p=0.015) and a long pre-procedure PR interval (OR 1.023; IC
1.001-1.046; p=0.038) were predictive factors of new persistent LBBB after
TAVI and a trend with CV implantation was observed (OR 2.35; IC 0.99-
5.53; p=0.051). NYHA grade was increased in the LBBB group compared to
non-LBBB group at 1 (2,1 ± 0,8 vs 1,7 ± 0,6 ; p=0.006), 6 (2,21 ± 0,7 vs
1,53±0,6 ; p=0.001) and 12 months (2.2 vs 1.7, p=0.04). 
On univariate analysis, a pre-existing atrial fibrillation (OR 2.1; IC 1.12-
4.01; p=0.021), an initial mean aortic gradient (OR 0.78; IC 0.65-0.93;
p=0.006) and new LBBB after TAVI (OR 2.06; IC 1.05-4.04; p=0.036) were
predictive factors of mortality at 12 months. On multivariate analysis, LBBB
after TAVI was an independent predictor of mortality (OR 3.52; IC 1.17-
10.58, p=0.025).
Conclusion: New-onset LBBB is frequent after TAVI and persists in a
great proportion of patients. In our study, LBBB after TAVI was an indepen-
dent predictor of mortality.
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Transfemoral tricuspid valve-in-valve and valve-in-ring implantation
using the Edwards SAPIEN XT valve: one-year follow-up
Caroline Nguyen, Claire Bouleti, Dominique Himbert, Eric Brochet,
Phalla Ou, Bernard Iung, Mohammed Nejjari, Walid Ghodbane, Jean Pol
Depoix, Amir-Ali Fassa, Alec Vahanian
APHP-Hôpital Bichat-Claude Bernard, Paris, France
Background: Redo tricuspid surgery may be at high risk or even contra-
indicated in patients with comorbidities. Transcatheter valve implantation
(TVI) has been recently reported in this setting. The aim of this study was to
evaluate the early and 1-year outcomes of TVI with Edwards SAPIEN XT
valves in failed tricuspid bioprostheses (BP) and ring annuloplasty (RA).
Methods and Results: TVI was performed in 6 patients for failed tricuspid
surgical valves (3 BP, 3 RA). Median patient age was 58 years, all were in
New York Heart Association (NYHA) class≥III and 5 out of 6 had previously
undergone at least 2 cardiac interventions.
The procedure was successful in the 3 patients with BP and 2 with RA; one
patient had a moderate paravalvular regurgitation at the level of the open por-
tion of a rigid incomplete ring. Otherwise, regurgitation was absent in
3 patients, trace in 1 and mild in 1. The transvalvular gradient decreased from
8 mmHg at baseline to 4 mmHg at day 7.
At 1-year follow-up, survival was 100%. Tricuspid gradients remained
stable in all but 1 patient, as well as regurgitation grades. Only 1 patient was
in NYHA class III, 2 were in class II and 3 in class I.
Conclusions: Transfemoral TVI with SAPIEN XT valves after failed tri-
cuspid surgery is feasible in selected high-risk patients, with good early and
1-year hemodynamic and clinical results. However, RA may raise issues due
to their oval shape and open configuration.
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Pulmonary hypertension and transcatheter aortic valve implantation:
prevalence, prognosis impact and evolution
Bastien Glinel, Fabrice Bauer
CHU Rouen, Cardiologie, Rouen, France
Background: In patients undergoing transcatheter aortic valve implanta-
tion, measurement of pulmonary pressure may help to stratify the clinical risk.
However, data may lead to patient misclassification and the role of pulmonary
vascular resistance which include cardiac output has never been investigated.
Methods and Results: One hundred and seventy one consecutive patients
with significant symptomatic aortic stenosis (aortic valve area <1 cm² or
0.6 cm²/m²) who prospectively were scheduled for transaortic valve implanta-
tion, underwent preoperative right-sided heart catheterization and quantitative
Doppler echocardiography. Of these, 99 (57.9 %) had pulmonary hypertension
[invasive mean pulmonary artery pressure (PAP) ≥25mm Hg] and 40 experi-
enced cardiac events during a 1-year follow-up (readmission for heart failure
in 16 patients, sudden and non-cardiac death in 24). In univariate analysis,
patients who had cardiac events exhibited a higher both peak systolic PAP
(46.9±12.1 versus 40.8±12,0mm Hg; P=0.026) and transpulmonary pressure
gradient (12.6±4.5 versus 10.1±3,7mm Hg; P=0.011), as well as increased pul-
monary vascular resistance (PVR, 2.7±1.0 vs. 2.0±0.8 WU, p = 0.002). Peak
systolic PAP>40mm Hg and PVR>2.05 WU were selected by receiver oper-
ating curve for predicting cardiac events with the best sensitivity and speci-
ficity. By multivariate Cox regression analysis, independent predictors of
cardiac events were as follows: body mass index (P=0.005), a mitral regurgi-
tation (P=0.018), and a spectrum of peak systolic PAP>40mm Hg with simul-
taneous PVR>2.05 WU compared with other patients [2.6 (1.39-4.89),
p=0.003].
Conclusions: Right heart catheterization could be useful to identify a high-
risk subset of aortic stenosis patients candidate for transcatheter aortic valve
implantation and help for clinical decision making.
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